Stroke, the leading cause of disability

Every year millions of people suffer a stroke and remain permanently, severely paralyzed.
Without any hope for recovery.

17 million

New cases per year, worldwide


of patients with severe paralysis


Cost of stroke in EU and the US

Changing stroke rehab

Intento has developed an easy-to-use, effective solution to help severely paralyzed stroke patients recover motor function in upper limbs. Even several years after the stroke.

Our solution is based on functional electrical stimulation and does not require any prior knowledge on electrode placement or involve complicated steps to configure the system, as opposed to other solutions on the market.

Intento's device is composed by a tablet application meant to be used by therapists in conjunction with a simple device for patient-use.

Patients use the device with the healthy hand, to generate and control the delivery of electrical stimulation on the affected side of the body. Thanks to our device, patients can control again their paretic limb and engage into physical therapy and retraining of activities of daily living.

Move Immediately

Patients can move again and be in control of the impaired arm, even with a complete hemiparesis. Bring back the motivation to the patients, without any additional tool.

Easy set-up

Treat with a single, easy-to-use tool mildly to severely paralyzed stroke patients. No prior expertise in electrical stimulation is needed. The system can be set-up in less than 5 minutes on a patient.

Quantify Progress

We track type and amount of exercises performed by the patient, allowing doctors and therapists to follow patient recovery and progress.

A hope for recovery

Data provided for medical professionals only, device not yet FDA approved or on sale in the US

A first, proof-of-concept clinical study has tested the therapeutic principle that will be implemented into our device, and has shown that the majority of patients doing rehabilitation with Intento’s solution have displayed a clinically important recovery, against those that took conventional therapy. This happens already after two weeks of treatment. We carefully crafted the exercises delivered by our system during therapy to maximize the potential for recovery. You can read more on the study here.



Showed clinically important recovery

* more than 5 points on the Fugl Meyer Assessment for Upper-Extremity, 1 patient displayed increase after wash-out period



Showed very large recovery

* more than 10 points on the Fugl-Meyer Assessment for Upper-Extremity


To see evident benefits

from the beginning of the therapy


Intento SA is a spin-off company of the Swiss Federal Institute of Technology in Lausanne, founded in 2016, and based in Ecublens, Switzerland.

Andrea Maesani, PhD

Co-founder & CEO

Andrea is an enthusiastic engineer, scientist, and entrepreneur. He holds a MSc in Computer Engineering from Politecnico di Milano and a PhD in artificial intelligence from EPFL. He has more than 10 years of experience in software engineering, and during his research he acquired a wide expertise in artificial intelligence, robotics, computational neuroscience, and neuroprosthetics for stroke rehab. Andrea is shaping Intento's core technology to bring on the market an effective, evidence-based solution for rehabilitation.

Grégoire Heitz

Chief Technology Officer

Grégoire holds a MSc in Electronic Engineering from Ecole de Chimie et Physique in Lyon. He has more than six years of experience in electronic design and embedded software development, and he is currently leading the development of Intento devices. He carefully designs every details of the electronics at the core of Intento devices, striving to merge robust engineering with elegant designs.

Alice Tonazzini, PhD

R&D & clinical affairs

Alice is a biomedical engineer with a PhD in Biorobotics at Scuola Superiore Sant'Anna (Pisa, Italy). She is an expert in smart materials and soft robotics, and has authored several scientific publications and patents. Alice is currently taking care of developing the wearable devices that will power the next generation of Intento's neuroprosthetic devices developed, and structuring clinical research performed at Intento.

Awards & Support